One such company offering alternatives to conventional microarrays is Illumina of San Diego, California. The company's bead-based technology is available on two distinct substrates, the Sentrix ...

The Illumina facility is located in the Bristol Bioresource Laboratories, at Oakfield House, University of Bristol. We offer Illumina microarray processing and expertise accessible to both internal ...

Illumina (ILMN – Research Report) received a Hold rating and price target from Citi analyst Patrick B Donnelly yesterday. The company’s ...

In a report released on December 8, Conor McNamara from RBC Capital maintained a Buy rating on Illumina (ILMN – Research Report), with a price ...

Analysts on Wall Street project that Illumina (ILMN ... Analysts expect 'Revenue- Microarrays- Instruments' to come in at $4.63 million. The estimate suggests a change of -7.4% year over year.

The Leukemia & Lymphoma Society estimates that by year end, 2024 will have seen 187,740 Americans diagnosed with a blood ...

Illumina, Inc. engages in the development ... Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting.